8 days ago
EWTX
AnalystsTessa RomeroTessa Romero's Stock Forecasts
AnalystsTessa Romero
Sectors:
Industries:
Analyst Ranking
Top 16%
#842 out of 5226 analysts
Average Return
+14.25%
Win Rate
40%26 out of 65
Risk vs Reward
Poor
Good
Tessa Romero's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +397.74% | $7.07 | $35.19 | 2024-10-02 - 2025-10-02 | Strong Buy |
Dyne Therapeutics IncDYN | +307.09% | $10.58 | $43.07 | 2023-08-08 - 2024-08-08 | Strong Buy |
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-03 - 2024-01-03 | Strong Buy |
Edgewise Therapeutics IncEWTX | +132.39% | $7.75 | $18.01 | 2023-06-29 - 2024-06-28 | Strong Buy |
Edgewise Therapeutics IncEWTX | +122.03% | $13.80 | $30.64 | 2025-08-18 - 2026-03-24 | Strong Buy |
Tessa Romero Analyst Color
Get additional color on Tessa Romero's coverage of popular stocks
9 days ago
SRRK
21 days ago
ACAD
3 months ago
XENE
4 months ago
XENE
4 months ago
SRRK
4 months ago
EWTX
a year ago
BHVN
2 years ago
CYTK
2 years ago
BHVN
Tessa Romero's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Septerna IncSEPN | 1 | Strong Buy | $38.00 | +62.12% | Maintains | a day ago |
Edgewise Therapeutics IncEWTX | 11 | Strong Buy | $45.00 | +46.87% | Maintains | 8 days ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $75.00 | +24.96% | Maintains | 8 days ago |
Scholar Rock Holding CorpSRRK | 6 | Strong Buy | $50.00 | +18.20% | Maintains | 9 days ago |
Acadia Pharmaceuticals IncACAD | 12 | Strong Buy | $34.00 | +62.21% | Maintains | 21 days ago |
Dyne Therapeutics IncDYN | 8 | Hold | $16.00 | -10.36% | Maintains | 2 months ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $62.00 | +16.15% | Maintains | 3 months ago |
Agios Pharmaceuticals IncAGIO | 8 | Hold | $25.00 | -11.82% | Maintains | 3 months ago |
Oculis Holding AgOCS | 1 | Strong Buy | $38.00 | +54.98% | Initiates Coverage On | 3 months ago |
Biohaven LtdBHVN | 8 | Strong Buy | $15.00 | +78.78% | Maintains | 4 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Sell | $263.00 | +6,059.25% | Downgrades | 4 months ago |
Lexeo Therapeutics IncLXEO | 2 | Strong Buy | $10.00 | +81.82% | Maintains | 10 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 4 | Hold | $15.00 | N/A | Downgrades | a year ago |
Eyepoint IncEYPT | 3 | Strong Buy | $29.00 | N/A | Maintains | 2 years ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | N/A | Maintains | 3 years ago |
Seres Therapeutics IncMCRB | 1 | Hold | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.